Source:http://linkedlifedata.com/resource/pubmed/id/15656699
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
2005-1-19
|
| pubmed:abstractText |
Posaconazole is a potent, extended-spectrum triazole antifungal agent currently in clinical development for the treatment of invasive fungal infections. This study was conducted to compare the bioavailability and resulting serum concentrations of posaconazole 800 mg following administration of three different dose regimens to fasting adults.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0312-5963
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
44
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
211-20
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:15656699-Administration, Oral,
pubmed-meshheading:15656699-Adult,
pubmed-meshheading:15656699-Biological Availability,
pubmed-meshheading:15656699-Cross-Over Studies,
pubmed-meshheading:15656699-Drug Administration Schedule,
pubmed-meshheading:15656699-Fasting,
pubmed-meshheading:15656699-Humans,
pubmed-meshheading:15656699-Male,
pubmed-meshheading:15656699-Models, Biological,
pubmed-meshheading:15656699-Triazoles
|
| pubmed:year |
2005
|
| pubmed:articleTitle |
Oral bioavailability of posaconazole in fasted healthy subjects: comparison between three regimens and basis for clinical dosage recommendations.
|
| pubmed:affiliation |
Schering-Plough Research Institute, Kenilworth, New Jersey 07033, USA.
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|